W.G. Honer

1.2k total citations
30 papers, 862 citations indexed

About

W.G. Honer is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, W.G. Honer has authored 30 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 6 papers in Cognitive Neuroscience and 5 papers in Molecular Biology. Recurrent topics in W.G. Honer's work include Schizophrenia research and treatment (9 papers), Bipolar Disorder and Treatment (5 papers) and Advanced Neuroimaging Techniques and Applications (5 papers). W.G. Honer is often cited by papers focused on Schizophrenia research and treatment (9 papers), Bipolar Disorder and Treatment (5 papers) and Advanced Neuroimaging Techniques and Applications (5 papers). W.G. Honer collaborates with scholars based in Canada, United States and Italy. W.G. Honer's co-authors include Donna J. Lang, Peter Falkai, Vina M. Goghari, J. John Mann, Andrew J. Dwork, Sean W. Flynn, Alex L. MacKay, Victoria Arango, Irene Vavasour and Kenneth P. Whittall and has published in prestigious journals such as Biological Psychiatry, Cerebral Cortex and Neuropsychopharmacology.

In The Last Decade

W.G. Honer

29 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.G. Honer Canada 11 220 213 206 187 171 30 862
Daniel G. Stewart United States 8 602 2.7× 277 1.3× 203 1.0× 271 1.4× 473 2.8× 10 1.2k
Elif M. Sikoglu United States 15 134 0.6× 173 0.8× 113 0.5× 135 0.7× 254 1.5× 24 790
Sabine Hellwig Germany 21 240 1.1× 225 1.1× 408 2.0× 288 1.5× 171 1.0× 62 1.6k
Zhifeng Zhou United States 13 74 0.3× 326 1.5× 297 1.4× 118 0.6× 232 1.4× 20 839
Mario Vukšić Croatia 14 58 0.3× 210 1.0× 335 1.6× 85 0.5× 195 1.1× 28 1.0k
V.I. Rachmanova Russia 8 398 1.8× 354 1.7× 376 1.8× 266 1.4× 364 2.1× 12 1.3k
Olga Vikhreva Russia 11 289 1.3× 266 1.2× 252 1.2× 153 0.8× 235 1.4× 31 1.0k
Kathrin Nickel Germany 19 115 0.5× 204 1.0× 117 0.6× 236 1.3× 399 2.3× 85 1.2k
Kolomeets Ns Russia 12 229 1.0× 332 1.6× 395 1.9× 171 0.9× 278 1.6× 41 1.1k
Yun Tan United States 26 55 0.3× 343 1.6× 267 1.3× 329 1.8× 177 1.0× 67 1.5k

Countries citing papers authored by W.G. Honer

Since Specialization
Citations

This map shows the geographic impact of W.G. Honer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.G. Honer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.G. Honer more than expected).

Fields of papers citing papers by W.G. Honer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.G. Honer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.G. Honer. The network helps show where W.G. Honer may publish in the future.

Co-authorship network of co-authors of W.G. Honer

This figure shows the co-authorship network connecting the top 25 collaborators of W.G. Honer. A scholar is included among the top collaborators of W.G. Honer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.G. Honer. W.G. Honer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bücker, Joana, Kesavan Muralidharan, Ivan J. Torres, et al.. (2013). Childhood maltreatment and corpus callosum volume in recently diagnosed patients with bipolar I disorder: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Journal of Psychiatric Research. 48(1). 65–72. 17 indexed citations
2.
Chen, Eric, Christy Lai Ming Hui, Sherry Kit Wa Chan, et al.. (2012). Three-year outcome of phase-specific early intervention for first-episode psychosis: a cohort study in Hong Kong.. PubMed. 18 Suppl 6. 7–13. 7 indexed citations
3.
Falkai, Peter, Berend Malchow, Jason D. Huber, et al.. (2012). EFFECTS OF INDOOR CYCLING ON HIPPOCAMPAL STRUCTURE, METABOLISM AND CLINICAL FEATURES OF SCHIZOPHRENIA. Schizophrenia Research. 136. S56–S56. 1 indexed citations
4.
Boyda, Heidi N., Ric M. Procyshyn, Lurdes Tse, et al.. (2011). Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats. Neuropharmacology. 62(3). 1391–1400. 42 indexed citations
5.
Lang, Donna J., et al.. (2010). Anterior internal capsule volumes increase in patients with schizophrenia switched from typical antipsychotics to olanzapine. Journal of Psychopharmacology. 25(5). 621–629. 11 indexed citations
6.
Hui, Christy Lai Ming, et al.. (2008). Can we predict relapse in single episode psychosis patients with stable maintenance treatment for at least one year. Early Intervention in Psychiatry. 1 indexed citations
7.
Hippman, Catriona, Tim F. Oberlander, W.G. Honer, Shaila Misri, & Jehannine Austin. (2008). Depression during pregnancy: the potential impact of increased risk for fetal aneuploidy on maternal mood. Clinical Genetics. 75(1). 30–36. 16 indexed citations
8.
Austin, Jehannine & W.G. Honer. (2004). The potential impact of genetic counseling for mental illness. Clinical Genetics. 67(2). 134–142. 50 indexed citations
9.
Flynn, Sean W., Donna J. Lang, Alex L. MacKay, et al.. (2003). Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Molecular Psychiatry. 8(9). 811–820. 351 indexed citations
10.
Falkai, Peter, et al.. (2003). Second replication of disturbed pre-alpha-cell migration in the entorhinal cortex of schizophrenic patients. Schizophrenia Research. 60(1). 71–71. 4 indexed citations
11.
Tee, Karen, et al.. (2003). Pathways into care in early psychosis. Schizophrenia Research. 60(1). 38–38.
12.
Honer, W.G.. (2002). Abnormalities of SNARE Mechanism Proteins in Anterior Frontal Cortex in Severe Mental Illness. Cerebral Cortex. 12(4). 349–356. 110 indexed citations
13.
Young, Clint E., Peter Falkai, & W.G. Honer. (2000). Increased myelin basic protein in BA 10 white matter in schizophrenia. Schizophrenia Research. 41(1). 111–111. 1 indexed citations
14.
Vicente, Astrid M., et al.. (1997). NCAM and schizophrenia: genetic studies. Molecular Psychiatry. 2(1). 65–69. 33 indexed citations
15.
Kopala, Lili C., et al.. (1996). Olfactory deficits in familial schizophrenia. Schizophrenia Research. 18(2-3). 244–244. 1 indexed citations
16.
Honer, W.G.. (1995). Regional Cortical Anatomy and Clozapine Response in Refractory Schizophrenia. Neuropsychopharmacology. 13(1). 85–87. 33 indexed citations
17.
Sidenberg, Deborah, Lidia Demchyshyn, Hyman B. Niznik, et al.. (1993). New Polymorphism for the Human Serotonin 1D Receptor Variant (5-HT<sub>1D&beta;</sub>) not Linked to Schizophrenia in Five Canadian Pedigrees. Human Heredity. 43(5). 315–318. 31 indexed citations
18.
Kennedy, James L., Hubert H.M. Van Tol, Artūras Petronis, et al.. (1993). Dopamine D4 receptor gene variants and schizophrenia. Schizophrenia Research. 9(2-3). 119–119. 3 indexed citations
19.
Petronis, Artūras, et al.. (1993). Investigation of genetic risk factors for schizophrenia on 11q. Schizophrenia Research. 9(2-3). 122–122. 2 indexed citations
20.
Honer, W.G., et al.. (1987). Temporal Lobe Involvement in Multiple Sclerosis Patients With Psychiatric Disorders. Archives of Neurology. 44(2). 187–190. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026